Peter Attia· MD
so it's really if if he's right it's really a change not so much in the amount of tor complex 2 but in its target specificity which particular substrates it modifies and which ones it stops modifying that's a subtlety that may be the whole story there as to why changes in mtar complex 2 should be a part of any sophisticated study of this drug and other drugs